The follicular hormonal profile in low-responder patients undergoing unstimulated cycles: Is it hypoandrogenic? 2013

M J de los Santos, and V García-Laez, and D Beltrán, and E Labarta, and Jose Luis Zuzuarregui, and P Alamá, and P Gámiz, and J Crespo, and E Bosch, and A Pellicer
Clinical Embryology Laboratory, IVI Valencia, Institut Universitari IVI, Plaza de la Policía Local, 346016 Valencia, Spain.

OBJECTIVE What is the final hormonal milieu of pre-ovulatory follicles of low-responder (LR) patients undergoing unstimulated cycles? CONCLUSIONS Neither androgen secretion nor LH was impaired in pre-ovulatory follicles of LR women. BACKGROUND Therapies currently used to improve ovarian response in LR women have an impact on the final hormonal follicular milieu, and these changes are believed to be partially responsible for determining the success rate in these women. Surprisingly, as far as we know, there is no report of the final hormonal profile of LR women undergoing unstimulated cycles or evidence that follicular androgen secretion in LR women is impaired. METHODS A prospective case-control study including 94 women, 36 normal controls and 58 LR patients (19 Young ≤ 35 years LR and 39 Aged >35 years LR) from 2009 to 2011. METHODS Fifty-eight LR women were divided into two groups: Young LR (age ≤ 35; n = 19) and Aged LR (ALR; age >35; n = 39). The control group (group C) comprised 36 egg donors undergoing an unstimulated cycle in our IVF unit. Serum and follicular fluid hormonal concentrations for estradiol (E₂), progesterone, testosterone and androstendione were measured. The spindle parameters of metaphase II oocytes generated from these groups were also analysed. RESULTS Pre-ovulatory follicles from LR patients had similar androgenic and LH concentrations to those observed in the control group. However, higher intrafollicular concentrations of FSH and progesterone were observed in ALR. Moreover, no differences were found for the spindle evaluation of oocytes between groups by the Oosight technology. CONCLUSIONS The controls were younger and had a lower BMI than the LR women. The sample size available restricted statistical power. CONCLUSIONS This study suggests that the problem with LR women is not the final pre-ovulatory follicular androgen concentration since this is similar to normal responders, but in the ability to respond to controlled ovarian stimulation protocols. Therefore, efforts should be focused on long-interval androgen priming to potentially increase the recruitment of small antral follicles rather than increasing the intraovarian androgen levels within the current cycle. BACKGROUND The present project has been supported by the R+D programme from the Generalitat Valenciana (Regional Valencian Government) IMPIVA MIDTF/2010/95. The authors have no conflict of interest to declare.

UI MeSH Term Description Entries
D007247 Infertility, Female Diminished or absent ability of a female to achieve conception. Sterility, Female,Sterility, Postpartum,Sub-Fertility, Female,Subfertility, Female,Female Infertility,Female Sterility,Female Sub-Fertility,Female Subfertility,Postpartum Sterility,Sub Fertility, Female
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D008677 Metaphase The phase of cell nucleus division following PROMETAPHASE, in which the CHROMOSOMES line up across the equatorial plane of the SPINDLE APPARATUS prior to separation.
D008941 Spindle Apparatus A microtubule structure that forms during CELL DIVISION. It consists of two SPINDLE POLES, and sets of MICROTUBULES that may include the astral microtubules, the polar microtubules, and the kinetochore microtubules. Mitotic Apparatus,Mitotic Spindle Apparatus,Spindle Apparatus, Mitotic,Meiotic Spindle,Meiotic Spindle Apparatus,Mitotic Spindle,Apparatus, Meiotic Spindle,Apparatus, Mitotic,Apparatus, Mitotic Spindle,Apparatus, Spindle,Meiotic Spindles,Mitotic Spindles,Spindle Apparatus, Meiotic,Spindle, Meiotic,Spindle, Mitotic,Spindles, Meiotic,Spindles, Mitotic
D009865 Oocytes Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM). Ovocytes,Oocyte,Ovocyte
D010062 Ovulation Induction Techniques for the artifical induction of ovulation, the rupture of the follicle and release of the ovum. Ovarian Stimulation,Ovarian Stimulations,Stimulation, Ovarian,Stimulations, Ovarian
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females

Related Publications

M J de los Santos, and V García-Laez, and D Beltrán, and E Labarta, and Jose Luis Zuzuarregui, and P Alamá, and P Gámiz, and J Crespo, and E Bosch, and A Pellicer
January 1998, Human reproduction (Oxford, England),
M J de los Santos, and V García-Laez, and D Beltrán, and E Labarta, and Jose Luis Zuzuarregui, and P Alamá, and P Gámiz, and J Crespo, and E Bosch, and A Pellicer
June 2011, Reproductive biology and endocrinology : RB&E,
M J de los Santos, and V García-Laez, and D Beltrán, and E Labarta, and Jose Luis Zuzuarregui, and P Alamá, and P Gámiz, and J Crespo, and E Bosch, and A Pellicer
March 2022, Journal of the Turkish German Gynecological Association,
M J de los Santos, and V García-Laez, and D Beltrán, and E Labarta, and Jose Luis Zuzuarregui, and P Alamá, and P Gámiz, and J Crespo, and E Bosch, and A Pellicer
September 2007, Gynecologie, obstetrique & fertilite,
M J de los Santos, and V García-Laez, and D Beltrán, and E Labarta, and Jose Luis Zuzuarregui, and P Alamá, and P Gámiz, and J Crespo, and E Bosch, and A Pellicer
July 1995, Journal of assisted reproduction and genetics,
M J de los Santos, and V García-Laez, and D Beltrán, and E Labarta, and Jose Luis Zuzuarregui, and P Alamá, and P Gámiz, and J Crespo, and E Bosch, and A Pellicer
January 1991, Fertility and sterility,
M J de los Santos, and V García-Laez, and D Beltrán, and E Labarta, and Jose Luis Zuzuarregui, and P Alamá, and P Gámiz, and J Crespo, and E Bosch, and A Pellicer
June 2021, BMC pregnancy and childbirth,
M J de los Santos, and V García-Laez, and D Beltrán, and E Labarta, and Jose Luis Zuzuarregui, and P Alamá, and P Gámiz, and J Crespo, and E Bosch, and A Pellicer
March 1991, Human reproduction (Oxford, England),
M J de los Santos, and V García-Laez, and D Beltrán, and E Labarta, and Jose Luis Zuzuarregui, and P Alamá, and P Gámiz, and J Crespo, and E Bosch, and A Pellicer
May 1991, Human reproduction (Oxford, England),
M J de los Santos, and V García-Laez, and D Beltrán, and E Labarta, and Jose Luis Zuzuarregui, and P Alamá, and P Gámiz, and J Crespo, and E Bosch, and A Pellicer
December 2007, International journal of andrology,
Copied contents to your clipboard!